Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11066)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2020 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu BJ, Gao S, Zhu X, Guo JH, Zhang X, Chen H, Wang XD, Yang RJ. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(6): 663-676 [PMID: 32699581 DOI: 10.4251/wjgo.v12.i6.663] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i6/663.htm |
| Number | Citing Articles |
| 1 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu, Xin Zhang, Xiao-Dong Wang, Guang Cao, Hui Chen, Peng Liu, Hai-Feng Xu, Qin-Zong Gao, Ren-Jie Yang. Real-world Study of Hepatic Artery Infusion Chemotherapy Combined With Anti-PD-1 Immunotherapy and Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma. Immunotherapy 2021; 13(17): 1395 doi: 10.2217/imt-2021-0192
|
| 2 |
Wenfang Ma, Zukuan Chang, Shixing Li, Xiuhua Wang, Guangshao Cao, Youjie Fan. Predictive value of serum miR-21 and miR-122 expression on the efficacy of capecitabine combined with transcatheter hepatic arterial embolization chemotherapy for liver metastasis after colorectal cancer surgery in patients with colorectal cancer and construction and verification of nomograms. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1604994
|
| 3 |
Baojiang Liu, Song Gao, Jianhai Guo, Fuxin Kou, Shaoxing Liu, Xin Zhang, Aiwei Feng, Xiaodong Wang, Guang Cao, Liang Xu, Hui Chen, Peng Liu, Haifeng Xu, Qinzong Gao, Renjie Yang, Xu Zhu. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy. International Immunopharmacology 2024; 130: 111767 doi: 10.1016/j.intimp.2024.111767
|
| 4 |
Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Ferdinando Carlo Sasso. HCC and Molecular Targeting Therapies: Back to the Future. Biomedicines 2021; 9(10): 1345 doi: 10.3390/biomedicines9101345
|
| 5 |
Yixin Ding, Shasha Wang, Zhenkang Qiu, Chunyang Zhu, Yan Wang, Shufen Zhao, Wensheng Qiu, Kongjia Wang, Jing Lv, Weiwei Qi. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1284937
|
| 6 |
Abdul Rehman Khan, Xuyong Wei, Xiao Xu. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides. Journal of Hepatocellular Carcinoma 2021; : 1089 doi: 10.2147/JHC.S318070
|
| 7 |
Yi Li, Dan Li, Qianqian Liu, Jun Li. Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer. Pancreas 2024; 53(6): e537 doi: 10.1097/MPA.0000000000002328
|
| 8 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu, Xin Zhang, Xiao-Dong Wang, Guang Cao, Hui Chen, Peng Liu, Lin-Zhong Zhu, Hai-Feng Xu, Ren-Jie Yang, Rong Liu. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score‐Matched Analysis. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6670367
|
| 9 |
Baojiang Liu, Song Gao, Jianhai Guo, Fuxin Kou, Shaoxing Liu, Xin Zhang, Aiwei Feng, Xiaodong Wang, Guang Cao, Hui Chen, Peng Liu, Haifeng Xu, Qinzong Gao, Renjie Yang, Liang Xu, Xu Zhu. Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 477 doi: 10.2147/JHC.S452120
|
| 10 |
Mingyue Cai, Licong Liang, Jian Zhang, Nianping Chen, Wensou Huang, Yongjian Guo, Xiaotao Hong, Liteng Lin, Yaohong Liu, Cao Dan, Haihui Deng, Xiaoguang Liu, Jingwen Zhou, Ye Chen, Huanwei Chen, Kangshun Zhu. Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study. International Journal of Surgery 2024; 110(12): 7860 doi: 10.1097/JS9.0000000000001819
|
| 11 |
Cheng Zhang, Yuyan Xu, Lei Cai, Shuyi Zhou, Jianan Feng, Shunjun Fu, Weidong Wang, Weichao Liang, Chang Li, Weixu Guo, Minghui Tan, Haisu Tao, Sulai Liu, Jian Yang, Mingxin Pan. Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-08170-4
|
| 12 |
Chao An, Mengxuan Zuo, Wang Li, Qifeng Chen, Peihong Wu. Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.747496
|
| 13 |
Guang Cao, Xiaodong Wang, Hui Chen, Song Gao, Jianhai Guo, Peng Liu, Haifeng Xu, Liang Xu, Xu Zhu, Renjie Yang. Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02344-4
|
| 14 |
Bin Chen, Haitao Dai, Jianyong Yang, Guiyuan Zhang, Chunyong Wen, Xianhong Xiang, Run Lin, Yonghui Huang. Transarterial Chemoembolization Followed by Hepatic Arterial Infusion
Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of
Large Hepatocellular Carcinoma. Current Cancer Drug Targets 2023; 23(7): 564 doi: 10.2174/1568009623666230215142941
|
| 15 |
Sarah El-Nakeep, Anup Kasi. Editorial: Hepatocellular carcinoma: from personalized medicine to practical guidelines. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1301202
|
| 16 |
Jun Yang, Shen Zhang, Yu Yin, Zhi Li, Shitao Lu, Guanyin Ni, Xiaoli Zhu, Caifang Ni. Efficacy and safety of hepatic arterial infusion chemotherapy followed by transarterial embolization for hepatocellular carcinoma. Tumori Journal 2025; 111(2): 158 doi: 10.1177/03008916251327830
|
| 17 |
Binkui Li, Jiliang Qiu, Yun Zheng, Yunxing Shi, Ruhai Zou, Wei He, Yichuang Yuan, Yuanping Zhang, Chenwei Wang, Zhiyu Qiu, Kai Li, Chengrui Zhong, Yunfei Yuan. Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma. Annals of Surgery Open 2021; 2(2): e057 doi: 10.1097/AS9.0000000000000057
|